Modern strategies for self-monitoring: new era of effective diabetes management

Svetlova, O.; Gur'eva, Irina Vladimirovna; Савченко, Л. С.

doi:10.21518/2079-701x-2019-4-30-33

Medicinskij sovet

2019

DOI: 10.21518/2079-701x-2019-4-30-33

|View full text |Cite

Modern strategies for self-monitoring: new era of effective diabetes management

O. Svetlova¹,

Irina Vladimirovna Gur'eva²,

Л. С. Савченко³

Abstract: Светлова Ольга Владимировна-к.м.н., врачэндокринолог, заведующая кабинетом «Школа сахарного диабета» научно-практического сектора профилактики и реабилитации инвалидности вследствие эндокринной патологии Фе де рального государственного бюджетного учреждения «Федеральное бюро медико-социальной экспертизы» Министерства труда и соци альной защиты Российской Федера ции; тел.:

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

2024

Publication Types

Select...

Article2

Relationship

Self Cite2

Independent0

Authors

Journals

Cited by 2 publications

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Innovative technologies in the management of diabetes mellitus: prevention of hypoglycemia

Svetlova¹,

Gurieva

2023

Medicinskij sovet

Self Cite

View full text Add to dashboard Cite

One of the strategies for preventing hypoglycemia, along with structured patient education and the use of modern hypoglycemic agents, is self-control of glycemia with the achievement of individual therapeutic goals. Frequently recurring hypoglycemic episodes are associated with impaired recognition of hypoglycemia and increase the risk of severe hypoglycemia up to six times. Prevention of the development of severe hypoglycemia may be of key importance for the prevention of adverse cardiovascular events and the risk of sudden death in patients with diabetes mellitus. Repeated hypoglycemic episodes can lead to impaired recognition of hypoglycemia, as a result of which a lower blood glucose level is necessary for the development of clinical symptoms of hypoglycemia. The use of individual glucose meters is currently relevant, despite the active introduction into clinical practice of continuous monitoring of glycemia and flash monitoring. ccording to the Russian “Algorithms of specialized medical care for patients with diabetes mellitus”, patients are recommended to conduct self-monitoring using individual glucose meters at least 4 times a day when using continuous monitoring of glycemia in real time and at least 2 times a day when using flash monitoring of glycemia to assess accuracy and / or calibration monitoring data and in order to resolve the issue of correction of ongoing therapy. The desire for strict and adequate self-control dictates the need to use the latest means of glycemia control – intelligent glucose meters with high accuracy, ease of use and reliability of blood glucose measurements. The introduction of intelligent technologies – “smart” glucose meters using a mobile application, with the functions of “no coding”, “second chance”, data transmission to the attending physician – makes it possible to carry out remote monitoring, providing more effective management of diabetes mellitus.

show abstract

Innovative technologies in the management of diabetes mellitus: prevention of hypoglycemia

Svetlova¹,

Gurieva

2023

Medicinskij sovet

Self Cite

View full text Add to dashboard Cite

show abstract

Problems and decisions in the management of type 2 diabetes mellitus: the role of metformin

Svetlova,

Gurieva,

Kuzina

et al. 2024

Medicinskij sovet

Self Cite

View full text Add to dashboard Cite

Studies on the additional properties of metformin continue despite the long period of its use as an antihyperglycemic drug. Metformin is a member of the biguanide class of drugs and is successfully used for many years in type 2 diabetes mellitus patients with normal weight, overweight, and obesity both in monotherapy and in combination with other sugar-lowering drugs. It can be used as a drug for the management of T2DM due to its high sugar-lowering activity, low risk of hypoglycemia when used as monotherapy, neutral effect on weight with its further moderate reduction, good safety profile, and availability for most patients. A decreased peripheral insulin resistance under the influence of metformin leads to increased utilization of glucose in the liver, muscles and adipose tissue, which results in an antihyperglycemic effect and, as a consequence of this, improvement of the disease management, preventing or slowing down the development of late complications of type 2 diabetes mellitus. Metformin has a proven track record as a drug with many positive effects, which was confirmed in numerous studies in patients with various complications of diabetes mellitus and concomitant pathologies. The article presents data on the use of metformin in patients with type 2 diabetes mellitus for the purpose of preventing sarcopenic obesity and managing its symptoms. Metformin presents some features of interest in preventing the development and treatment of non-alcoholic fatty liver disease and polycystic ovary syndrome.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Modern strategies for self-monitoring: new era of effective diabetes management

Cited by 2 publications

References 6 publications

Innovative technologies in the management of diabetes mellitus: prevention of hypoglycemia

Innovative technologies in the management of diabetes mellitus: prevention of hypoglycemia

Problems and decisions in the management of type 2 diabetes mellitus: the role of metformin

Contact Info

Product

Resources

About